1. Home
  2. XFOR vs ISSC Comparison

XFOR vs ISSC Comparison

Compare XFOR & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XFOR
  • ISSC
  • Stock Information
  • Founded
  • XFOR 2014
  • ISSC 1988
  • Country
  • XFOR United States
  • ISSC United States
  • Employees
  • XFOR N/A
  • ISSC N/A
  • Industry
  • XFOR Biotechnology: Biological Products (No Diagnostic Substances)
  • ISSC EDP Services
  • Sector
  • XFOR Health Care
  • ISSC Technology
  • Exchange
  • XFOR Nasdaq
  • ISSC Nasdaq
  • Market Cap
  • XFOR 118.4M
  • ISSC 106.9M
  • IPO Year
  • XFOR N/A
  • ISSC 2000
  • Fundamental
  • Price
  • XFOR $3.40
  • ISSC $11.19
  • Analyst Decision
  • XFOR Strong Buy
  • ISSC
  • Analyst Count
  • XFOR 3
  • ISSC 0
  • Target Price
  • XFOR $72.33
  • ISSC N/A
  • AVG Volume (30 Days)
  • XFOR 180.2K
  • ISSC 230.3K
  • Earning Date
  • XFOR 05-01-2025
  • ISSC 05-14-2025
  • Dividend Yield
  • XFOR N/A
  • ISSC N/A
  • EPS Growth
  • XFOR N/A
  • ISSC 68.61
  • EPS
  • XFOR 2.16
  • ISSC 0.61
  • Revenue
  • XFOR $31,364,000.00
  • ISSC $65,055,384.00
  • Revenue This Year
  • XFOR $915.88
  • ISSC $31.35
  • Revenue Next Year
  • XFOR N/A
  • ISSC $16.39
  • P/E Ratio
  • XFOR $1.57
  • ISSC $18.34
  • Revenue Growth
  • XFOR N/A
  • ISSC 58.67
  • 52 Week Low
  • XFOR $2.67
  • ISSC $5.25
  • 52 Week High
  • XFOR $33.90
  • ISSC $12.17
  • Technical
  • Relative Strength Index (RSI)
  • XFOR 39.83
  • ISSC 74.56
  • Support Level
  • XFOR $2.67
  • ISSC $9.90
  • Resistance Level
  • XFOR $3.56
  • ISSC $11.33
  • Average True Range (ATR)
  • XFOR 0.28
  • ISSC 0.60
  • MACD
  • XFOR 0.21
  • ISSC 0.20
  • Stochastic Oscillator
  • XFOR 82.02
  • ISSC 96.81

About XFOR X4 Pharmaceuticals Inc.

X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: